MTLF Stock Chart & Stats
308.00
<0.01(0.24%)
At close: 4:00 PM EST
308.00
<0.01(0.24%)
Day’s Range― - ―
52-Week Range204.00 - 853.00
Previous CloseN/A
Volume5.01K
Average Volume (3M)63.03K
Market Cap
₪79.15M
Enterprise Value30.21M
Total Cash (Recent Filing)₪21.81M
Total Debt (Recent Filing)₪800.00K
Price to Earnings (P/E)―
Beta0.74
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.96
Shares Outstanding30,314,121
10 Day Avg. Volume70,393
30 Day Avg. Volume63,031
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)10.09
Price to Sales (P/S)0.00
P/FCF Ratio-6.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Matricelf News
MTLF FAQ
What was Matricelf Ltd.’s price range in the past 12 months?
Matricelf Ltd. lowest stock price was 204.00 and its highest was 853.00 in the past 12 months.
What is Matricelf Ltd.’s market cap?
Matricelf Ltd.’s market cap is ₪79.15M.
When is Matricelf Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Matricelf Ltd.’s earnings last quarter?
Currently, no data Available
Is Matricelf Ltd. overvalued?
According to Wall Street analysts Matricelf Ltd.’s price is currently Overvalued.
Does Matricelf Ltd. pay dividends?
Matricelf Ltd. does not currently pay dividends.
What is Matricelf Ltd.’s EPS estimate?
Matricelf Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Matricelf Ltd. have?
Matricelf Ltd. has 30,314,121 shares outstanding.
What happened to Matricelf Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Matricelf Ltd.?
Currently, no hedge funds are holding shares in IL:MTLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Matricelf Ltd.
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury. The company has a strategic collaboration with CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.